169 related articles for article (PubMed ID: 36599284)
21. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
22. Reprogramming of dermal fibroblasts from a Duchenne muscular dystrophy patient carrying a deletion of exons 45-50 into an induced pluripotent stem cell line (CCMi005-A).
Rovina D; Castiglioni E; Mallia S; Rabino M; Farini A; Belicchi M; Di Giuseppe G; Gervasini C; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2022 Oct; 64():102889. PubMed ID: 35961103
[TBL] [Abstract][Full Text] [Related]
23. Generation and validation of an iPSC line (BBANTWi008-A) from a Loeys-Dietz Syndrome type 3 patient.
Velchev JD; Verstraeten A; Meester J; Ponsaerts P; Richer J; Alaerts M; Loeys B
Stem Cell Res; 2022 Oct; 64():102932. PubMed ID: 36219981
[TBL] [Abstract][Full Text] [Related]
24. Generation of induced pluripotent stem cell (iPSC) line from a 21-year-old X-linked adrenoleukodystrophy (X-ALD) patient.
You YR; Son D; Kang PJ; You S; Kim DS
Stem Cell Res; 2017 Dec; 25():136-138. PubMed ID: 29128817
[TBL] [Abstract][Full Text] [Related]
25. Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome.
Wang YB; Lv YF; Zhang Y; Wang W
Stem Cell Res; 2024 Mar; 75():103318. PubMed ID: 38295749
[TBL] [Abstract][Full Text] [Related]
26. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
[TBL] [Abstract][Full Text] [Related]
27. Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus.
Tongkobpetch S; Rungsiwiwut R; Pruksananonda K; Suphapeetiporn K; Shotelersuk V
Stem Cell Res; 2019 Aug; 39():101493. PubMed ID: 31326747
[TBL] [Abstract][Full Text] [Related]
28. Establishment of an induced pluripotent stem (iPS) cell line from dermal fibroblasts of an asymptomatic patient with dominant PRPF31 mutation.
Terray A; Fort V; Slembrouck A; Nanteau C; Sahel JA; Reichman S; Audo I; Goureau O
Stem Cell Res; 2017 Dec; 25():26-29. PubMed ID: 29040912
[TBL] [Abstract][Full Text] [Related]
29. Generation of an urine-derived induced pluripotent stem cell line from a 5-year old X-linked Alport syndrome (X-LAS) patient.
Guo X; Ji W; Niu C; Ding Y; Chen Z; Chen C; Tong H; Han Z; Chu M
Stem Cell Res; 2020 Dec; 49():102085. PubMed ID: 33202306
[TBL] [Abstract][Full Text] [Related]
30. Expanding the clinical spectrum of biglycan-related Meester-Loeys syndrome.
Meester JAN; Hebert A; Bastiaansen M; Rabaut L; Bastianen J; Boeckx N; Ashcroft K; Atwal PS; Benichou A; Billon C; Blankensteijn JD; Brennan P; Bucks SA; Campbell IM; Conrad S; Curtis SL; Dasouki M; Dent CL; Eden J; Goel H; Hartill V; Houweling AC; Isidor B; Jackson N; Koopman P; Korpioja A; Kraatari-Tiri M; Kuulavainen L; Lee K; Low KJ; Lu AC; McManus ML; Oakley SP; Oliver J; Organ NM; Overwater E; Revencu N; Trainer AH; Trivedi B; Turner CLS; Whittington R; Zankl A; Zentner D; Van Laer L; Verstraeten A; Loeys BL
NPJ Genom Med; 2024 Mar; 9(1):22. PubMed ID: 38531898
[TBL] [Abstract][Full Text] [Related]
31. Generation of two induced pluripotent stem cell lines (LVPEIi007-B, LVPEIi008-B) from patients harboring homozygous mutation in ABCA4 (c.6088C>T) using non-integrative Sendai virus-based approach.
Pidishetty D; Maddileti S; Mahato S; Agrawal T; Pulimamidi VK; Naik M; Kannabiran C; Jalali S; Mariappan I
Stem Cell Res; 2024 Jun; 77():103418. PubMed ID: 38615588
[TBL] [Abstract][Full Text] [Related]
32. Generation of human iPSC line from a patient with Tetralogy of Fallot, YAHKMUi001-A, carrying a mutation in TBX1 gene.
Han S; Zhang YY; Meng MY; Hou ZL; Meng P; Zhao YY; Gao H; Tang J; Liu Z; Yang LL; Jiang LH; Li YX
Stem Cell Res; 2020 Jan; 42():101687. PubMed ID: 31869684
[TBL] [Abstract][Full Text] [Related]
33. Generation of the human induced pluripotent stem cell line UKWNLi002-A from dermal fibroblasts of a woman with a heterozygous c.608 C>T (p.Thr203Met) mutation in exon 3 of the nerve growth factor gene potentially associated with hereditary sensory and autonomic neuropathy type 5.
Klein T; Henkel L; Klug K; Kwok CK; Klopocki E; Üçeyler N
Stem Cell Res; 2018 Dec; 33():171-174. PubMed ID: 30384131
[TBL] [Abstract][Full Text] [Related]
34. Generation of the induced pluripotent stem cell line UHOMi001-A from a patient with mutations in CCDC40 gene causing Primary Ciliary Dyskinesia (PCD).
Ahmed E; Sansac C; Fieldes M; Bergougnoux A; Bourguignon C; Mianné J; Arnould C; Vachier I; Assou S; Bourdin A; De Vos J
Stem Cell Res; 2018 Dec; 33():15-19. PubMed ID: 30296669
[TBL] [Abstract][Full Text] [Related]
35. Human pluripotent stem cell line (HDZi001-A) derived from a patient carrying the ARVC-5 associated mutation TMEM43-p.S358L.
Ratnavadivel S; Szymanski de Toledo M; Rasmussen TB; Šarić T; Gummert J; Zenke M; Milting H
Stem Cell Res; 2020 Oct; 48():101957. PubMed ID: 32858485
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
[TBL] [Abstract][Full Text] [Related]
37. Generation of an induced pluripotent stem cell (iPSC) line (JUCTCi017-A) from a patient with limb-girdle muscular dystrophy (LGMD) due to a homozygous p.Lue287Ser fs14* mutation in the SGCB gene.
Ababneh NA; Barham R; Al-Kurdi B; Ali D; Sharar N; Al Hadidi S; Alatoom RM; Zalloum S; Gharandouq MH; Makahleh L; Alnsour LN; Alshahwan H; El-Khateeb M; Awidi A
Stem Cell Res; 2021 Jul; 54():102358. PubMed ID: 34087734
[TBL] [Abstract][Full Text] [Related]
38. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
[TBL] [Abstract][Full Text] [Related]
39. Generation of an iPSC line from skin fibroblasts of a patient with Joubert syndrome carrying the homozygous loss of function variant c.787dupC in the AHI1 gene.
Serpieri V; Orsi A; Mazzotta C; Cavan S; Rossi E; Scelsa B; Valente EM
Stem Cell Res; 2023 Feb; 66():103002. PubMed ID: 36521382
[TBL] [Abstract][Full Text] [Related]
40. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
